Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor
Molecular Pharmacology (2006) - Comments
pubmed: 16887935  doi: 10.1124/mol.106.023911  issn: 0026-895x  issn: 1521-0111 

Ping-Hui Tseng, Yu-Chieh Wang, Shu-Chuan Weng, Jing-Ru Weng, Ching-Shih Chen, Robert W. Brueggemeier, Charles L. Shapiro, Ching-Yu Chen, Sandra E. Dunn, Michael Pollak, Ching-Shih Chen